• Danya Reich
  • Corinna Eleni Psomadakis
  • Bobby Buka


A 24-year-old female came in to Primary Care for evaluation of a rash that had started in her finger webbings and eventually extended to her arms and right hip. The rash was diagnosed as scabies, an infestation by the ectoparasite Sarcoptes scabiei that causes diffuse itchiness and excoriations. The rash typically affects interdigital web spaces, wrists, elbows, axilla, and the groin. Scabies is a highly infectious condition that is spread by skin-to-skin contact or, less frequently, through contact with shared clothes or linens. It can affect individuals of all ages, races, and genders. Immunocompromised individuals are particularly vulnerable and may experience a more severe form of the disease, known as Norwegian or crusted scabies. The mites are treated with permethrin 5 % cream applied from the neck to the feet once at night and washed off the following morning. A second treatment is repeated a week later. Oral ivermectin is the antiparasitic of choice for infestations that do not resolve after topical therapy.


Scabies Excoriation Pruritus Mites Sarcoptes scabiei Burrows Infestation Parasite Ectoparasite Contagious Neglected disease 


  1. 1.
    Currie BJ, McCarthy JS. Permethrin and ivermectin for scabies. N Engl J Med. 2010;362(8):717–25.CrossRefPubMedGoogle Scholar
  2. 2.
    Burkhart CN, Burkhart CG. Chapter 208. Scabies, other mites, and pediculosis. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, editors. Fitzpatrick’s dermatology in general medicine. 8th ed. New York: McGraw-Hill; 2012. Available from: Accessed 22 Feb 2015.Google Scholar
  3. 3.
    Shimose L, Munoz-Price LS. Diagnosis, prevention, and treatment of scabies. Curr Infect Dis Rep. 2013;15(5):426–31.CrossRefPubMedGoogle Scholar
  4. 4.
    FitzGerald D, Grainger RJ, Reid A. Intervention for preventing the spread of infestation in close contact of people with scabies. Cochrane Database Syst Rev. 2014;2, CD009943.Google Scholar
  5. 5.
    Karimkhani C, Boyers LN, Prescott L, Welch V, Delamere FM, Nasser M, Zaveri A, Hay RJ, Vos T, Murray CJ, Margolis DJ, Hilton J, MacLehose H, Williams HC, Dellavalle RP. Global burden of skin disease as reflected in Cochrane Database of Systematic Reviews. JAMA Dermatol. 2014;150(9):945–51.CrossRefPubMedGoogle Scholar
  6. 6.
    Ranjkesh MR, Naghili B, Goldust M, Rezaee E. The efficacy of permethrin 5% vs. oral ivermectin for the treatment of scabies. Ann Parasitol. 2013;59(4):189–94.PubMedGoogle Scholar
  7. 7.
    Sharma R, Singal A. Topical permethrin and oral ivermectin in the management of scabies: a prospective, randomized, double blind, controlled study. Indian J Dermatol Venereol Leprol. 2011;77:581–6.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Open Access This chapter is distributed under the terms of the Creative Commons Attribution Noncommercial License, which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Authors and Affiliations

  • Danya Reich
    • 1
  • Corinna Eleni Psomadakis
    • 2
  • Bobby Buka
    • 3
  1. 1.Department of Family MedicineMount Sinai School of Medicine Attending Mount Sinai Doctors/Beth Israel Medical Group-WilliamsburgBrooklynUSA
  2. 2.School of Medicine Imperial College LondonLondonUK
  3. 3.Department of DermatologyMount Sinai School of MedicineNew YorkUSA

Personalised recommendations